Kamal Eltayeb

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Istituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro(Current)

University of Parma

Kamal Eltayeb is an author at Istituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2022–2024

Publications

PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC)

Andrea Cavazzoni, Graziana Digiacomo, Francesco Volta et al. · Lung Cancer · 2023 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +17

CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells

Graziana Digiacomo, Claudia Fumarola, Silvia La Monica et al. · Frontiers in Oncology · 2022 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines

Kamal Eltayeb, Roberta Alfieri, Claudia Fumarola et al. · Biochemical Pharmacology · 2024 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models

Silvia La Monica, Federica Vacondio, Kamal Eltayeb et al. · Scientific Reports · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4